Mark Parry, Intertek Pharmaceutical Services - Qepler Summits And Conferences

Mark Parry

Technical Director
Intertek Pharmaceutical Services
United Kingdom
Intertek Pharmaceutical Services

Mark Parry has worked with Intertek Melbourn for almost 20 years after graduating from Cambridge University and currently works as the Technical Director. Mark has worked in a range of pharmaceutical analysis and formulation development areas with a particular focus on inhaled and nasal drug products.

Mostly working in the pre-approval stages, Mark’s background includes extensive experience with product and formulation development, as well as method development and validation, stability studies, and pharmaceutical development activities for a wide range of clients across the pharmaceutical industry.

Mark currently works as the Technical Director, supporting the wide range of analytical, formulation and product development activities across the company.

Related Sessions:

2nd Annual Inhaled
Drug Delivery Summit 2021

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 05 Aug 2021
  • Virtual,
  • Pharma
Day 2: Friday, 06 August 2021
CASE STUDY: Translating Inhaled and Nasal Technologies for the Delivery of Biologics.

    Inhaled and nasal delivery platforms have specific applications outside of their traditional uses for asthma/chronic obstructive pulmonary disease (COPD) and seasonal rhinitis/sinusitis: They can offer real advantages for the delivery of therapeutic biologics.

  • Overview of currently available technologies and successfully marketed products.
  • Review of the development challenges that might be encountered — and the solutions that are available — when formulating these delivery routes.
  • A focus on analytical approaches for impurity identification and quantification.
  • Key considerations when rapidly repurposing existing products for inhaled delivery.
View Details